Granuloma faciale and Takayasu arteritis in a child: a case report

Wei LIAO, Juan LONG, Jian-Ping TANG, Dan-Ni WO, Ye SHU, Zhu WEI

Chinese Journal of Contemporary Pediatrics ›› 2025, Vol. 27 ›› Issue (10) : 1266-1270.

PDF(885 KB)
PDF(885 KB)
Chinese Journal of Contemporary Pediatrics ›› 2025, Vol. 27 ›› Issue (10) : 1266-1270. DOI: 10.7499/j.issn.1008-8830.2504185
RARE DISEASE RESEARCH

Granuloma faciale and Takayasu arteritis in a child: a case report

Author information +
History +

Abstract

An 11-year-old boy presented with erythematous plaques over the bilateral mandibular and mental regions for 2 years, accompanied by cough and dyspnea for more than 2 months. Chest computed tomography angiography revealed marked stenosis of the right pulmonary artery, irregular aortic caliber, and aortic wall thickening. Histopathological examination of the skin lesion, including immunohistochemistry and special stains, confirmed a chronic suppurative inflammation. Whole-exome sequencing was negative. A final diagnosis of granuloma faciale and Takayasu arteritis was established. Combination therapy with systemic tocilizumab, prednisone, and methotrexate, along with topical 0.1% tacrolimus ointment, resulted in a favorable clinical response. This report summarizes the clinical features of a pediatric case of granuloma faciale and Takayasu arteritis and reviews the etiology, diagnostic approach, and current treatment strategies for the disorders, aiming to enhance clinicians' understanding of these conditions.

Key words

Granuloma faciale / Takayasu arteritis / Child

Cite this article

Download Citations
Wei LIAO , Juan LONG , Jian-Ping TANG , et al . Granuloma faciale and Takayasu arteritis in a child: a case report[J]. Chinese Journal of Contemporary Pediatrics. 2025, 27(10): 1266-1270 https://doi.org/10.7499/j.issn.1008-8830.2504185

References

[1]
Al Dhafiri M, Kaliyadan F. Granuloma Faciale[M]//StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2025.
[2]
Sia JK, Rengarajan J. Immunology of Mycobacterium tuberculosis infections[J]. Microbiol Spectr, 2019, 7(4): 10.1128/microbiolspec.gpp3-0022-2018. PMID: 31298204 PMCID:PMC6636855. DOI: 10.1128/microbiolspec.GPP3-0022-2018 .
[3]
Fang YH, Wei KC, Yu MS. Improvement of erythema elevatum diutinum refractory to dapsone following treatment for underlying multiple myeloma[J]. Eur J Dermatol, 2021, 31(5): 655-657. DOI: 10.1684/ejd.2021.4131 .
[4]
Marcoval J, Moreno A, Peyr J. Granuloma faciale: a clinicopathological study of 11 cases[J]. J Am Acad Dermatol, 2004, 51(2): 269-273. DOI: 10.1016/j.jaad.2003.11.071 .
[5]
Stone JH, Khosroshahi A, Zhang W, et al. Inebilizumab for treatment of IgG4-related disease[J]. N Engl J Med, 2025, 392(12): 1168-1177. DOI: 10.1056/NEJMoa2409712 .
[6]
Cesinaro AM, Lonardi S, Facchetti F. Granuloma faciale: a cutaneous lesion sharing features with IgG4-associated sclerosing diseases[J]. Am J Surg Pathol, 2013, 37(1): 66-73. DOI: 10.1097/PAS.0b013e318271efd0 .
[7]
Pinkus H. Granuloma faciale[J]. Dermatologic, 1952, 105(2): 85-99.
[8]
Oliveira CC, Ianhez PE, Marques SA, et al. Granuloma faciale: clinical, morphological and immunohistochemical aspects in a series of 10 patients[J]. An Bras Dermatol, 2016, 91(6): 803-807. PMCID: PMC5193193. DOI: 10.1590/abd1806-4841.20164628 .
[9]
Ortonne N, Wechsler J, Bagot M, et al. Granuloma faciale: a clinicopathologic study of 66 patients[J]. J Am Acad Dermatol, 2005, 53(6): 1002-1009. DOI: 10.1016/j.jaad.2005.08.021 .
[10]
Chen A, Harview CL, Rand SE, et al. Refractory granuloma faciale successfully treated with adjunct topical JAK inhibitor[J]. JAAD Case Rep, 2023, 33: 91-94. PMCID: PMC9989295. DOI: 10.1016/j.jdcr.2023.01.016 .
[11]
Nakahara T, Moroi Y, Tashiro A, et al. The interaction of inflammatory cells in granuloma faciale[J]. Dermatol Reports, 2010, 2(2): e17. PMCID: PMC4211470. DOI: 10.4081/dr.2010.e17 .
[12]
Lindhaus C, Elsner P. Granuloma faciale treatment: a systematic review[J]. Acta Derm Venereol, 2018, 98(1): 14-18. DOI: 10.2340/00015555-2784 .
[13]
Giannitti C, Nami N, Rubegni P, et al. Granuloma faciale, rheumatoid arthritis and Sjögren syndrome: is there a link?[J]. J Cutan Pathol, 2013, 40(8): 770-771. DOI: 10.1111/cup.12115 .
[14]
Sambhariya WS, Campbell A. Rapidly growing eyelid lesion in a 73-year-old man[J]. JAMA Ophthalmol, 2024, 142(8): 777-778. DOI: 10.1001/jamaophthalmol.2024.1807 .
[15]
Morgado-Carrasco D, Giavedoni P, Mascaró JM, et al. Assessment of treatment of refractory granuloma faciale with intralesional rituximab[J]. JAMA Dermatol, 2018, 154(11): 1312-1315. PMCID: PMC6248127. DOI: 10.1001/jamadermatol.2018.2681 .
[16]
李天英, 郑松. 面部肉芽肿一例[J]. 中华病理学杂志, 2017, 46(10): 729-730. DOI: 10.3760/cma.j.issn.0529-5807.2017.10.016 .
[17]
赵梦洁, 蒋思, 宋继权. 0.1%他克莫司软膏治疗面部肉芽肿1例[J]. 中华皮肤科杂志, 2024, 57(2): 168-169. DOI: 10.35541/cjd.20210512 .
[18]
Mastorino L, Avallone G, Dapavo P, et al. Tocilizumab and its usage for skin diseases[J]. Ital J Dermatol Venerol, 2022, 157(1): 13-22. DOI: 10.23736/S2784-8671.20.06772-3 .
[19]
刘娟, 曹雪涛. 2024年国内外免疫学研究重要进展[J]. 中国免疫学杂志, 2025, 41(1): 1-10. DOI: 10.3969/j.issn.1000-484X.2025.01.001 .
[20]
Nakaoka Y, Yanagawa M, Hata A, et al. Vascular imaging of patients with refractory Takayasu arteritis treated with tocilizumab: post hoc analysis of a randomized controlled trial[J]. Rheumatology (Oxford), 2022, 61(6): 2360-2368. PMCID: PMC9157117. DOI: 10.1093/rheumatology/keab684 .
[21]
Li H, Shuai Z. Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review[J]. Heart Vessels, 2022, 37(5): 884-894. PMCID: PMC8986741. DOI: 10.1007/s00380-021-01981-1 .

Footnotes

所有作者声明无利益冲突。

PDF(885 KB)

Accesses

Citation

Detail

Sections
Recommended

/